Class II · Moderate risk Ongoing
TopCare health
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Lithium Carbonate ER
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Labeling: Label Mixup: LITHIUM CARBONATE ER, Tablet, 300 mg may be potentially mislabled as the following drug: VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg, NDC 40985022251, Pedigree: AD39588_10, EXP: 5/13/2014.
What was recalled
LITHIUM CARBONATE ER, Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054002125.
- Recalling firm
- Aidapak Services, LLC
- Origin
- WA, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-791-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Carbonate recalls
See all
Class II · Moderate risk Ongoing
TopCare health
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk Ongoing
EQUALINE ultra strength
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk Ongoing
EQUALINE extra strength
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Class II · Moderate risk Ongoing
GOODSENSE Ultra Strength
Reason Presence of foreign substance: small metallic particles in chewable tablets.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.